Eyegate Pharmaceuticals, Inc. Warrants
EYEGW
EYEGW was delisted on the 5th of August, 2020.
4 hedge funds and large institutions have $20K invested in Eyegate Pharmaceuticals, Inc. Warrants in 2017 Q3 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and 0 closing their positions.
25% more capital invested
Capital invested by funds: $16K → $20K (+$4K)
0% more funds holding
Funds holding: 4 → 4 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
+$2.1K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
AIC
1
AWM Investment Company
New York
| $16K | – | – | – |
|
2
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $2K | – | – | – |
|
|
VF
3
Virtu Financial
New York
| $2K | +$2.1K | +20,581 | New |
|
EYEGW Hedge Fund Activity: Q3 2017 in Review
4 of the 4,012 institutional investors tracked by Wall St. Rank reported a position in Eyegate Pharmaceuticals, Inc. Warrants (EYEGW) for Q3 2017, worth a combined $20K — up 25% from $16K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new EYEGW positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Virtu Financial, opening a new position worth an estimated $2.1K.
- 4 institutional investors held Eyegate Pharmaceuticals, Inc. Warrants (EYEGW) as of Q3 2017, unchanged from Q2 2017.
- Funds reported $20K of Eyegate Pharmaceuticals, Inc. Warrants stock for Q3 2017, up 25% quarter-over-quarter.
- 1 fund opened new Eyegate Pharmaceuticals, Inc. Warrants positions in Q3 2017 and 0 closed out, a net change of +1 holder.
- The largest Eyegate Pharmaceuticals, Inc. Warrants buyer in Q3 2017 was Virtu Financial, an estimated $2.1K added.
Based on aggregated 13F filings for Q3 2017.